Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $37 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Corinne Jenkins raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $37.00 (from $35.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
